Florida has reduced funding and tightened eligibility for its AIDS Drug Assistance Program, limiting access to the widely used HIV medication Biktarvy for thousands of patients, while more than 20 ...

When Jayant Mishra was diagnosed with psoriatic arthritis last year, the California resident understood he’d likely need ...

Florida has one of the highest rates of new HIV diagnoses in the nation. Now, an estimated 16,000 Floridians have lost access to HIV and AIDS medications after an emergency rule from the Florida ...

The emergence of Lilly’s bundling strategy for Zepbound and Taltz reflects the unregulated state of patient assistance programs in the commercial market and the need for Congressional intervention.

Florida Governor Ron DeSantis is using his emergency powers to end coverage for an estimated 10,000 to 16,000 HIV/AIDS patients from the state's AIDS Drug Assistance Program, which advocates say could ...

The bill passed the Senate on a largely party line vote of 17 to 10 late last month. But according to Sen. Deb Patterson, a Salem Democrat who chairs the Senate Health Care Committee, she was told ...

Eighteen states are limiting access to HIV medications through ADAP programs as federal funding has remained largely flat despite rising costs, with others considering similar cuts.

Using a copay card has gotten trickier as insurers push back. First, patients need to understand whether there is an annual dollar or time limit on the card and how it works with their insurance.

Citing rising costs and shortfalls in federal support, about 20 states are toughening eligibility requirements for patients in drug assistance programs.

Using a copay card has gotten trickier as insurers push back. First, patients need to understand whether there is an annual ...

The state invoked emergency rule-making power for what advocates say will be another emergency, when HIV-positive patients ...

As health insurance companies push back against co-pay assistance programs, patients are left to navigate the complex world of prescription medication costs.